Kewaunee Scientific Corp
NASDAQ:KEQU
Balance Sheet
Balance Sheet Decomposition
Kewaunee Scientific Corp
Current Assets | 96.2m |
Cash & Short-Term Investments | 21.3m |
Receivables | 41.1m |
Other Current Assets | 33.7m |
Non-Current Assets | 30.1m |
PP&E | 25.3m |
Other Non-Current Assets | 4.8m |
Current Liabilities | 42.1m |
Accounts Payable | 19.1m |
Accrued Liabilities | 8.8m |
Short-Term Debt | 3.2m |
Other Current Liabilities | 11.1m |
Non-Current Liabilities | 40.1m |
Long-Term Debt | 27.9m |
Other Non-Current Liabilities | 12.2m |
Balance Sheet
Kewaunee Scientific Corp
Apr-2014 | Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
6
|
3
|
5
|
13
|
10
|
11
|
4
|
5
|
4
|
8
|
|
Cash Equivalents |
6
|
3
|
5
|
13
|
10
|
11
|
4
|
5
|
4
|
8
|
|
Total Receivables |
24
|
29
|
28
|
30
|
33
|
33
|
28
|
35
|
55
|
46
|
|
Accounts Receivables |
24
|
29
|
28
|
30
|
33
|
33
|
28
|
34
|
55
|
46
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Inventory |
12
|
13
|
16
|
15
|
19
|
17
|
15
|
17
|
24
|
22
|
|
Other Current Assets |
2
|
4
|
2
|
2
|
3
|
4
|
7
|
4
|
9
|
12
|
|
Total Current Assets |
43
|
49
|
51
|
60
|
64
|
65
|
54
|
61
|
92
|
88
|
|
PP&E Net |
15
|
15
|
14
|
14
|
15
|
17
|
26
|
25
|
23
|
26
|
|
PP&E Gross |
15
|
0
|
14
|
0
|
15
|
17
|
26
|
25
|
23
|
26
|
|
Accumulated Depreciation |
32
|
0
|
36
|
0
|
40
|
40
|
42
|
43
|
45
|
45
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
9
|
|
Other Long-Term Assets |
5
|
6
|
7
|
7
|
6
|
5
|
4
|
4
|
3
|
4
|
|
Total Assets |
63
N/A
|
70
+11%
|
72
+4%
|
81
+12%
|
85
+5%
|
87
+2%
|
84
-4%
|
89
+7%
|
119
+33%
|
119
+0%
|
|
Liabilities | |||||||||||
Accounts Payable |
9
|
11
|
12
|
12
|
15
|
15
|
13
|
17
|
27
|
24
|
|
Accrued Liabilities |
4
|
4
|
4
|
5
|
6
|
5
|
7
|
7
|
9
|
8
|
|
Short-Term Debt |
3
|
5
|
4
|
4
|
4
|
10
|
5
|
7
|
2
|
4
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
|
Other Current Liabilities |
0
|
0
|
1
|
6
|
2
|
2
|
3
|
3
|
4
|
4
|
|
Total Current Liabilities |
16
|
21
|
21
|
27
|
28
|
33
|
27
|
34
|
42
|
40
|
|
Long-Term Debt |
4
|
4
|
3
|
2
|
1
|
0
|
0
|
0
|
29
|
28
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Minority Interest |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
|
Other Liabilities |
8
|
10
|
10
|
8
|
8
|
7
|
18
|
13
|
11
|
11
|
|
Total Liabilities |
29
N/A
|
35
+20%
|
34
-1%
|
38
+11%
|
37
-2%
|
40
+7%
|
46
+13%
|
48
+6%
|
83
+73%
|
82
-2%
|
|
Equity | |||||||||||
Common Stock |
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
|
Retained Earnings |
32
|
34
|
37
|
40
|
44
|
44
|
38
|
34
|
28
|
29
|
|
Additional Paid In Capital |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
5
|
5
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
6
|
8
|
8
|
6
|
6
|
6
|
10
|
4
|
4
|
3
|
|
Total Equity |
34
N/A
|
35
+3%
|
38
+9%
|
43
+12%
|
48
+11%
|
47
-1%
|
38
-18%
|
41
+7%
|
36
-13%
|
37
+5%
|
|
Total Liabilities & Equity |
63
N/A
|
70
+11%
|
72
+4%
|
81
+12%
|
85
+5%
|
87
+2%
|
84
-4%
|
89
+7%
|
119
+33%
|
119
+0%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|